Published • loading... • Updated
Symbiotec Pharmalab Jumps 7.5% After US FDA Plant Report
Summary by equitypandit.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Symbiotec Pharmalab Jumps 7.5% After US FDA Plant Report
Shares of Symbiotec Pharmalab Ltd rose to a day high of Rs 1,136.00 on 29 September after its Pithampur plant got a favourable US FDA report. The company told exchanges that the US Food and Drug Administration has issued an Establishment Inspection Report, or EIR, for its Pithampur plant in...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
